Biologics license application - Wikipedia
WEBThe biologics license application is a request for permission to introduce, or deliver for introduction, a biologic product into interstate commerce (21 CFR 601.2). The BLA is regulated under 21 CFR 600 – 680.
What is a BLA (Biologics License Application)? Essential Guide for ...
WEBA Biologics License Application (BLA) is for biological products such as vaccines, blood products, and gene therapies, while a New Drug Application (NDA) is for the approval of small-molecule drugs and certain other therapeutic agents.
eCFR :: 21 CFR 601.2 -- Applications for biologics licenses; …
WEBTo obtain a biologics license under section 351 of the Public Health Service Act for any biological product, the manufacturer shall submit an application to the Director, Center for Biologics Evaluation and Research or the Director, Center for Drug Evaluation and Research (see mailing addresses in § 600.2(a) or (b) of this chapter), on forms ...
Types of Applications | FDA - U.S. Food and Drug Administration
WEBBiologic License Application (BLA) Biological products are approved for marketing under the provisions of the Public Health Service (PHS) Act. The Act requires a firm who manufactures a...
Development & Approval Process (CBER) | FDA - U.S. Food and …
WEBMay 4, 2023 · The Biologics License Application (BLA) is a request for permission to introduce, or deliver for introduction, a biologic product into interstate commerce (21 CFR 601.2).
The Biologics License Application (BLA) Process Explained - The …
WEBMar 28, 2022 · A biologics license application (BLA) is a request to distribute a biologic across states. It generally is submitted after an Investigational New Drug (IND) or an Investigational Device Exemption (IDE) and after the …
2024 Biological License Application Approvals | FDA
WEBJul 24, 2024 · This list reflects information regarding the applications as of the approval date. It is not updated with regard to applicant or application status changes. The applications are listed by...
Frequently Asked Questions About Therapeutic Biological Products
WEBWhereas a new drug application (NDA) is used for drugs subject to the drug approval provisions of the FDC Act, a biologics license application (BLA) is required for biological products...
2021 Biological License Application Approvals | FDA
WEBDec 20, 2021 · Development & Approval Process (CBER) 2021 Biological License Application Approvals. This list reflects information regarding the applications as of the approval date. It is not updated with...
WEBUnder the terms of 351(k)(7), the dates of licensure of 34 applications for certain changes to previously licensed biological products from the same or 35 certain related sponsors are...
- Some results have been removed